Multiparametric-MRI in Prostate Cancer

by admin_63069 | Oct 12, 2021 | Related Topics

Expert Marc A. Bjurlin, DO, MSc, FACOS, presents his view

What’s New

Treatment Options for High-Risk, Clinically Localized Prostate Cancer
Declassifying Gleason 6 as Cancer Would Do More Harm Than Good
The Efficacy and Safety of Relugolix vs Leuprolide
Staging, Grading and Risk Stratification
Testing

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org